Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115076) titled 'A prospective study based on CMR to evaluate cardiac damage and prognosis in PLWH under different ART regimens' on Dec. 22, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Public Health Clinical Center
Condition:
HIV
Intervention:
Control group:None
Non-Nucleoside Reverse Transcriptase Inhibitor Group:None
Protease Inhibitor Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Control group:50;Non-Nucleoside Reverse Transcriptase Inhibitor Group:100;Protease Inhibitor Group:100;Integrase Inhibitor G...